These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30506762)

  • 1. Paediatric community-acquired bacteraemia, pneumococcal invasive disease and antibiotic resistance fell after the pneumococcal conjugate vaccine was introduced.
    Berger Y; Adler A; Ariel T; Rokney A; Averbuch D; Grisaru-Soen G
    Acta Paediatr; 2019 Jul; 108(7):1321-1328. PubMed ID: 30506762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of pneumococcal conjugate vaccine-13 on the incidence of pediatric community-acquired bacteremia.
    Dabaja-Younis H; Geller D; Geffen Y; Almog R; Kassis I
    Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1433-1439. PubMed ID: 33537906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.
    Jones N; Huebner R; Khoosal M; Crewe-Brown H; Klugman K
    AIDS; 1998 Nov; 12(16):2177-84. PubMed ID: 9833859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotype prevalence of occult pneumococcal bacteremia.
    Alpern ER; Alessandrini EA; McGowan KL; Bell LM; Shaw KN
    Pediatrics; 2001 Aug; 108(2):E23. PubMed ID: 11483833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
    Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia.
    Steenhoff AP; Shah SS; Ratner AJ; Patil SM; McGowan KL
    Clin Infect Dis; 2006 Apr; 42(7):907-14. PubMed ID: 16511752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
    Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
    Flamaing J; Verhaegen J; Vandeven J; Verbiest N; Peetermans WE
    J Antimicrob Chemother; 2008 Jan; 61(1):143-9. PubMed ID: 17999974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency department epidemiology of pneumococcal bacteremia in children since the institution of widespread PCV7 vaccination.
    Mistry RD; Wedin T; Balamuth F; McGowan KL; Ellison AM; Nelson KA; McLoughlin RJ; Alpern ER
    J Emerg Med; 2013 Dec; 45(6):813-20. PubMed ID: 23992851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
    Kyaw MH; Lynfield R; Schaffner W; Craig AS; Hadler J; Reingold A; Thomas AR; Harrison LH; Bennett NM; Farley MM; Facklam RR; Jorgensen JH; Besser J; Zell ER; Schuchat A; Whitney CG;
    N Engl J Med; 2006 Apr; 354(14):1455-63. PubMed ID: 16598044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pneumococcal disease in Singapore children.
    Chong CY; Koh-Cheng T; Yee-Hui M; Nancy TW
    Vaccine; 2008 Jun; 26(27-28):3427-31. PubMed ID: 18499309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of community-acquired pneumonia hospitalisations before the introduction of pneumococcal conjugate vaccine into Polish National Immunisation Programme (2009-2016): A nationwide retrospective database analysis.
    Gajewska M; Goryński P; Paradowska-Stankiewicz I; Lewtak K; Piotrowicz M; Urban E; Cianciara D; Wysocki MJ; Książek A; Izurieta P
    Vaccine; 2020 Jan; 38(2):194-201. PubMed ID: 31653527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic and Microbiologic Characteristics of Occult Bacteremia Among Febrile Children in Southern Israel, Before and After Initiation of the Routine Antipneumococcal Immunization (2005-2012).
    Ribitzky-Eisner H; Minuhin Y; Greenberg D; Greenberg N; Chodick G; Craiu M; Leibovitz E
    Pediatr Neonatol; 2016 Oct; 57(5):378-384. PubMed ID: 26738763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.
    Black S; Shinefield H; Baxter R; Austrian R; Bracken L; Hansen J; Lewis E; Fireman B
    Pediatr Infect Dis J; 2004 Jun; 23(6):485-9. PubMed ID: 15194827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
    Kaplan SL; Mason EO; Wald ER; Schutze GE; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Yogev R; Barson WJ
    Pediatrics; 2004 Mar; 113(3 Pt 1):443-9. PubMed ID: 14993532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.